{"id":"https://openalex.org/W2054625537","doi":"https://doi.org/10.1038/clpt.2008.223","title":"From Darkness to Light With Biomarkers in Early Clinical Trials of Cancer Drugs","display_name":"From Darkness to Light With Biomarkers in Early Clinical Trials of Cancer Drugs","publication_year":2009,"publication_date":"2009-01-16","ids":{"openalex":"https://openalex.org/W2054625537","doi":"https://doi.org/10.1038/clpt.2008.223","mag":"2054625537","pmid":"https://pubmed.ncbi.nlm.nih.gov/19151637"},"language":"en","primary_location":{"id":"doi:10.1038/clpt.2008.223","doi":"https://doi.org/10.1038/clpt.2008.223","is_oa":false,"landing_page_url":"https://doi.org/10.1038/clpt.2008.223","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110430024","display_name":"C. P. Carden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I125671874","display_name":"National Health Service","ror":"https://ror.org/02wnqcb97","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I125671874","https://openalex.org/I1311074006"]},{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"CP Carden","raw_affiliation_strings":["The Royal Marsden National Health Service Foundation Trust, Sutton, Surrey, UK","The Institute of Cancer Research, Sutton, Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Royal Marsden National Health Service Foundation Trust, Sutton, Surrey, UK","institution_ids":["https://openalex.org/I125671874","https://openalex.org/I1325846038"]},{"raw_affiliation_string":"The Institute of Cancer Research, Sutton, Surrey, UK","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032401979","display_name":"Udai Banerji","orcid":"https://orcid.org/0000-0003-1503-3123","observed_orcids":["https://orcid.org/0000-0003-1503-3123"]},"institutions":[{"id":"https://openalex.org/I125671874","display_name":"National Health Service","ror":"https://ror.org/02wnqcb97","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I125671874","https://openalex.org/I1311074006"]},{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"U Banerji","raw_affiliation_strings":["The Institute of Cancer Research, Sutton, Surrey, UK","The Royal Marsden National Health Service Foundation Trust, Sutton, Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research, Sutton, Surrey, UK","institution_ids":["https://openalex.org/I142947616"]},{"raw_affiliation_string":"The Royal Marsden National Health Service Foundation Trust, Sutton, Surrey, UK","institution_ids":["https://openalex.org/I125671874","https://openalex.org/I1325846038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057815390","display_name":"Stuart B. Kaye","orcid":"https://orcid.org/0000-0003-4498-5537","observed_orcids":["https://orcid.org/0000-0003-4498-5537"]},"institutions":[{"id":"https://openalex.org/I125671874","display_name":"National Health Service","ror":"https://ror.org/02wnqcb97","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I125671874","https://openalex.org/I1311074006"]},{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"SB Kaye","raw_affiliation_strings":["The Institute of Cancer Research, Sutton, Surrey, UK","The Royal Marsden National Health Service Foundation Trust, Sutton, Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research, Sutton, Surrey, UK","institution_ids":["https://openalex.org/I142947616"]},{"raw_affiliation_string":"The Royal Marsden National Health Service Foundation Trust, Sutton, Surrey, UK","institution_ids":["https://openalex.org/I125671874","https://openalex.org/I1325846038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003965204","display_name":"Paul Workman","orcid":"https://orcid.org/0000-0003-1659-3034","observed_orcids":["https://orcid.org/0000-0003-1659-3034"]},"institutions":[{"id":"https://openalex.org/I125671874","display_name":"National Health Service","ror":"https://ror.org/02wnqcb97","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I125671874","https://openalex.org/I1311074006"]},{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"P Workman","raw_affiliation_strings":["The Institute of Cancer Research, Sutton, Surrey, UK","The Royal Marsden National Health Service Foundation Trust, Sutton, Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research, Sutton, Surrey, UK","institution_ids":["https://openalex.org/I142947616"]},{"raw_affiliation_string":"The Royal Marsden National Health Service Foundation Trust, Sutton, Surrey, UK","institution_ids":["https://openalex.org/I125671874","https://openalex.org/I1325846038"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[{"id":"https://openalex.org/I125671874","display_name":"National Health Service","ror":"https://ror.org/02wnqcb97","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I125671874","https://openalex.org/I1311074006"]},{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"JS de Bono","raw_affiliation_strings":["The Institute of Cancer Research, Sutton, Surrey, UK","The Royal Marsden National Health Service Foundation Trust, Sutton, Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research, Sutton, Surrey, UK","institution_ids":["https://openalex.org/I142947616"]},{"raw_affiliation_string":"The Royal Marsden National Health Service Foundation Trust, Sutton, Surrey, UK","institution_ids":["https://openalex.org/I125671874","https://openalex.org/I1325846038"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5072378199"],"corresponding_institution_ids":["https://openalex.org/I125671874","https://openalex.org/I1325846038","https://openalex.org/I142947616"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":6.6438,"has_fulltext":false,"cited_by_count":32,"citation_normalized_percentile":{"value":0.97212864,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"85","issue":"2","first_page":"131","last_page":"133"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.4496999979019165,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.4496999979019165,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.29420000314712524,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.09200000017881393,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.8619999885559082},{"id":"https://openalex.org/keywords/early-phase-trials","display_name":"early clinical trials","score":0.8460000157356262},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.6940000057220459},{"id":"https://openalex.org/keywords/molecularly-targeted-agents","display_name":"molecularly targeted agents","score":0.8330000042915344},{"id":"https://openalex.org/keywords/rational-drug-design","display_name":"rational drug design","score":0.6579999923706055},{"id":"https://openalex.org/keywords/oncogenic-signaling","display_name":"oncogenic signaling","score":0.6470000147819519},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.43299999833106995},{"id":"https://openalex.org/keywords/drug-attrition","display_name":"drug attrition","score":0.890999972820282}],"concepts":[{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.7385077476501465},{"id":"https://openalex.org/C63433958","wikidata":"https://www.wikidata.org/wiki/Q1774688","display_name":"Clinical pharmacology","level":2,"score":0.6272497773170471},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5951104760169983},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.5786118507385254},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5575844049453735},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5098592638969421},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.49136510491371155},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4678167998790741},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35753118991851807},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.32462984323501587},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.165230393409729}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D003624","descriptor_name":"Darkness","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008027","descriptor_name":"Light","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1038/clpt.2008.223","doi":"https://doi.org/10.1038/clpt.2008.223","is_oa":false,"landing_page_url":"https://doi.org/10.1038/clpt.2008.223","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics","raw_type":"journal-article"},{"id":"pmid:19151637","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19151637","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W1549144603","https://openalex.org/W1973268287","https://openalex.org/W2020995084","https://openalex.org/W2061050600","https://openalex.org/W2083927452","https://openalex.org/W2087012714","https://openalex.org/W2112417555","https://openalex.org/W2120590293","https://openalex.org/W2148998801","https://openalex.org/W2160180902","https://openalex.org/W2169644362","https://openalex.org/W2170544517"],"related_works":["https://openalex.org/W2043297836","https://openalex.org/W2103146352","https://openalex.org/W2133425730","https://openalex.org/W2064170540","https://openalex.org/W1549144603","https://openalex.org/W2161588876","https://openalex.org/W2568023268","https://openalex.org/W2223585524","https://openalex.org/W2087858402","https://openalex.org/W2199112889"],"abstract_inverted_index":{"Compared":[0],"with":[1],"conventional":[2],"chemotherapy,":[3],"rationally":[4],"designed":[5],"molecularly":[6],"targeted":[7,26],"agents":[8,48],"may":[9],"be":[10],"more":[11],"likely":[12],"to":[13,52,69],"have":[14],"antitumor":[15],"activity":[16],"in":[17,39],"selected":[18],"tumor":[19],"subgroups":[20],"driven":[21],"by":[22,27],"the":[23,40,50,62,67,79],"oncogenic":[24],"signals":[25],"these":[28,45],"compounds":[29],"and":[30,77,83],"a":[31],"different":[32],"side-effect":[33],"profile.":[34],"The":[35],"use":[36],"of":[37,44,81],"biomarkers":[38],"early":[41,58],"clinical":[42,59],"trials":[43],"new":[46],"anticancer":[47],"has":[49],"potential":[51],"increase":[53],"study":[54],"participants'":[55],"benefit":[56],"from":[57],"trials,":[60],"accelerate":[61],"drug":[63,85],"development":[64],"process,":[65],"maximize":[66],"ability":[68],"generate":[70],"important":[71],"biological":[72],"information":[73],"about":[74],"human":[75],"cancer,":[76],"decrease":[78],"risk":[80],"late":[82],"costly":[84],"attrition.":[86]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}